Regulatory pathway and market opportunity Marine Biomedical is nearing completion of its pivotal study to support a US FDA 510 (k) submission for PearlBone, which is targeted for the March quarter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback